- Filed
- Dec 11, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Dec 11, 2024 | 5.83M sh |
| Cash And Equivalents | Q2 2025 · Oct 31, 2024 | $8.06K |
| Current Liabilities | Q2 2025 · Oct 31, 2024 | $170.78K |
| Current Liabilities | Q2 2025 · Apr 30, 2024 | $117.82K |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $170.78K |
| Total Liabilities | Q2 2025 · Apr 30, 2024 | $117.82K |
| Current Assets | Q2 2025 · Oct 31, 2024 | $42.28K |
| Current Assets | Q2 2025 · Apr 30, 2024 | $73.6K |
| Total Assets | Q2 2025 · Oct 31, 2024 | $114.68K |
| Total Assets | Q2 2025 · Apr 30, 2024 | $86.77K |
| Cost Of Revenue | Q2 2025 · Oct 31, 2024 | $9.34K |
| Cost Of Revenue | Q2 2025 · Oct 31, 2024 | $13.74K |
| Cost Of Revenue | Q2 2025 · Oct 31, 2023 | $1.4K |
| Cost Of Revenue | Q2 2025 · Oct 31, 2023 | $1.4K |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | −$45.07K |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | −$26.5K |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | −$20.84K |
| Stockholders Equity | Q2 2025 · Apr 30, 2023 | −$13.42K |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 4.5M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 4.5M sh |
| Eps Basic | Q2 2025 · Oct 31, 2023 | $0.00 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | $0.00 |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $7.07K |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $14.5K |
| Net Income | Q2 2025 · Oct 31, 2023 | −$5.67K |
| Net Income | Q2 2025 · Oct 31, 2023 | −$13.09K |
| Operating Income restated | Q2 2025 · Oct 31, 2023 | −$5.67K |
| Operating Income restated | Q2 2025 · Oct 31, 2023 | −$13.1K |
| Revenue | Q2 2025 · Oct 31, 2023 | $1.4K |
| Revenue | Q2 2025 · Oct 31, 2023 | $1.4K |